Global Seasonal Affective Disorder Market – Industry Trends and Forecast to 2024
Market Analysis: Global Seasonal Affective Disorder Market
The Global Seasonal Affective Disorder Market accounted to USD 520.0 million in 2016 growing at a CAGR of 4.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Market Definition: Global Seasonal Affective Disorder Market
Seasonal affective disorder (SAD) is a type of depression or disorder which is related to changes in seasons. SAD frequently happens due to reducing light exposure to sunlight and occurs during a certain time of the year. Women are mostly affected with SAD who aged between 15 to 55 years.
Major Market Drivers and Restraints:
- Rise in geriatric population
- Increasing awareness among the people
- Favorable reimbursement scenario
- Change in lifestyle
- Growing market for generic drugs
Market Segmentation: Global Seasonal Affective Disorder Market
By type the global seasonal affective disorder market is segmented into fall and winter sad, spring and summer sad, others.
On the basis of diagnosis the global seasonal affective disorder market is segmented into physical exams, lab tests, psychological evaluation, others.
On the basis of treatment the global seasonal affective disorder market is segmented into phototherapy, medications, psychotherapy, counseling.
Psychotherapy is further sub segmented into art therapy, attachment-based psychotherapy, behavioral therapy, body psychotherapy, cognitive analytical therapy (cat), existential psychotherapy, gestalt therapy.
On the basis of end user the global seasonal affective disorder market is segmented into hospital, clinics, academic institutes, medical research centers.
On the basis of distribution channel the global seasonal affective disorder market is segmented into hospital pharmacies, retail pharmacies and drug stores, online pharmacies.
On the basis of geography, global seasonal affective disorder market report covers data points for 28 countries across multiple geographies such as North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.
Competitive Analysis: Global Seasonal Affective Disorder Market
The global seasonal affective disorder market is highly fragmented and is based on new product launches and clinical results of products. Hence the major players have used various strategies such as new product launches, clinical trials, market initiatives, high expense on research and development, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of seasonal affective disorder market for global, Europe, North America, Asia Pacific and South America.
Major Market Competitors: Global Seasonal Affective Disorder Market
Some of the major players operating in global seasonal affective disorder market are Janssen Pharmaceuticals, Inc., Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc., Sanofi, Eli Lilly and Company, Biogen, Bristol-Myers Squibb Company, Baxter, Novartis AG, Shire, AstraZeneca, Beurer GmbH, Koninklijke Philips N.V., Lumie, Verilux, Inc., AbbVie Inc., ALLARGAN, F. Hoffmann-La Roche Ltd., Henry Schein, Inc. among others.